Carnegie Capital Asset Management LLC reduced its holdings in Medidata Solutions Inc (NASDAQ:MDSO) by 7.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,840 shares of the company’s stock after selling 1,285 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in Medidata Solutions were worth $1,119,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of MDSO. Polen Capital Management LLC acquired a new stake in Medidata Solutions in the 3rd quarter valued at approximately $205,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Medidata Solutions by 48.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock valued at $205,000 after acquiring an additional 1,056 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in Medidata Solutions in the 2nd quarter valued at approximately $227,000. Hanseatic Management Services Inc. increased its position in Medidata Solutions by 14,915.0% in the 3rd quarter. Hanseatic Management Services Inc. now owns 3,003 shares of the company’s stock valued at $234,000 after acquiring an additional 2,983 shares during the period. Finally, Legato Capital Management LLC acquired a new stake in Medidata Solutions in the 3rd quarter valued at approximately $248,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.
Medidata Solutions Inc (MDSO) opened at $65.66 on Thursday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 3.37 and a current ratio of 1.50. The stock has a market capitalization of $3,931.36, a price-to-earnings ratio of 77.10, a price-to-earnings-growth ratio of 3.39 and a beta of 1.58. Medidata Solutions Inc has a one year low of $54.70 and a one year high of $85.92.
Several analysts recently commented on the company. Royal Bank of Canada set a $82.00 target price on Medidata Solutions and gave the company a “hold” rating in a research report on Thursday, February 8th. Dougherty & Co assumed coverage on Medidata Solutions in a research report on Thursday, November 2nd. They issued a “neutral” rating on the stock. Wells Fargo & Co upgraded Medidata Solutions from a “market perform” rating to an “outperform” rating and set a $80.00 target price on the stock in a research report on Friday, December 1st. TheStreet cut Medidata Solutions from a “b” rating to a “c+” rating in a research report on Thursday, December 14th. Finally, Zacks Investment Research upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Friday, November 10th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $82.07.
In other Medidata Solutions news, CFO Rouven Bergmann sold 2,000 shares of the stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $65.95, for a total transaction of $131,900.00. Following the completion of the transaction, the chief financial officer now directly owns 89,775 shares of the company’s stock, valued at approximately $5,920,661.25. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Over the last ninety days, insiders have sold 9,000 shares of company stock valued at $609,760. 5.80% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Carnegie Capital Asset Management LLC Has $1.12 Million Position in Medidata Solutions Inc (MDSO)” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3230577/carnegie-capital-asset-management-llc-has-1-12-million-position-in-medidata-solutions-inc-mdso.html.
Medidata Solutions Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.